Question 1

What is the projected market size and growth trajectory for the Singapore IVF Treatment Market between 2025 and 2030?

Accepted Answer

The Singapore IVF treatment market is forecast to reach USD 0.26 billion by 2030, demonstrating significant growth from its 2020 valuation of USD 0.10 billion. This expansion is projected at a Compound Annual Growth Rate (CAGR) of 9.71% from 2020 to 2030, indicating a robust upward trend.

Question 2

What are the key strategic drivers influencing the growth of the Singapore IVF treatment market, as identified in the report?

Accepted Answer

The report identifies several strategic drivers, including technological innovations in oocyte rejuvenation techniques, substantial government investments in biomedical research and clinical trials, and rising societal acceptance of delayed family planning. Additionally, strategic clinic expansions by healthcare providers are boosting specialized fertility services to meet growing demand.

Question 3

How do government initiatives and funding schemes specifically impact the demand for IVF and ART services in Singapore?

Accepted Answer

Government initiatives significantly boost demand, such as the 2022 scheme providing funding for pre-implantation genetic testing (PGT) during IVF treatment. The Marriage and Parenthood Schemes offer substantial subsidies, including 75% co-funding for various Assisted Reproduction Technology (ART) cycles—up to 3 fresh and 3 frozen cycles—making IVF and related treatments more financially accessible for Singaporean citizens.

Question 4

What are the primary factors contributing to Singapore's declining fertility rate, and how do they relate to the IVF market's outlook?

Accepted Answer

Singapore's total fertility rate is projected to fall to 0.97 live births per female in 2024, primarily due to high living costs and deferred childbearing as couples prioritize careers and changing lifestyles. This decline, coupled with an increasing trend of infertility, particularly among women aged 30-34, underscores the growing reliance on IVF treatments, which the government is actively supporting to counteract the low birth rate.

Question 5

What specific technological advancements in fertility treatments are highlighted as contributing to the Singapore IVF market's progress?

Accepted Answer

The report specifically highlights technological innovations in oocyte rejuvenation techniques as a key advancement driving progress in the Singapore IVF market. These techniques are crucial for restoring egg viability, which leads to improved outcomes in assisted reproduction and enhances the overall efficacy and success rates of fertility treatments.

Question 6

What types of Assisted Reproduction Technology (ART) cycles are covered by government co-funding within Singapore's IVF treatment market?

Accepted Answer

Government co-funding through schemes like the Marriage and Parenthood Schemes broadly covers Assisted Reproduction Technology (ART) services. This includes in-vitro fertilisation (IVF) and its variations such as IVF with or without ICSI, in-vitro maturation, donor cycles, and double stimulation, with support for a maximum of 3 fresh and 3 frozen ART cycles.

Singapore IVF Treatment Market - Strategic Insights and Forecasts (2025-2030)

Industry research on Singapore IVF treatment innovations, laboratory technologies, and fertility treatment expansion.

Market Segmentation

By Product Type

By Treatment Type

By End User

Analysis Of Key Market Players

Singapore Ivf Treatment Market Outlook

REPORT DETAILS

Need Assistance?